Investing

Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.

Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.

Here is a quick look at all the purchases made by ARK ETFs:

Fund Ticker Company Shares
ARKG ADPT Adaptive Biotechnologies 232,610
ARKG SRNG Soaring Eagle Acquisition 4,512,926
ARKG SGFY Signify Health 30,490
ARKK Z Zillow 101,994
ARKK TSP TuSimple 316,814
ARKK SRNG Soaring Eagle Acquisition 2,506,461
ARKQ MKFG Markforged 57,406
ARKQ PATH UiPath 8,178
ARKW LPSN LivePerson 22,696
ARKW Z Zillow 24,750
ARKW PATH UiPath 8,641
ARKX BLDE Blade Air Mobility 16,370
ARKX KTOS Kratos Defense & Security Solutions 49,634


Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.